Stay updated on Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now indicates that recruitment has ended and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) while removing the older 'Intervention / Treatment' entry and earlier revision notes.
    Difference
    1%
    Check dated 2026-06-13T00:30:19.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.5, replacing Revision: v3.5.4, indicating a new build of the page rather than a change to study data.
    Difference
    0.1%
    Check dated 2026-06-05T22:11:52.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    A new page revision (v3.5.4) replaces the previous v3.5.3, indicating a version update behind the scenes with no user-facing content changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T09:29:26.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    The page’s displayed software/document revision was updated from v3.5.2 to v3.5.3, indicating a minor backend or release update rather than a change to the clinical trial’s content.
    Difference
    0.1%
    Check dated 2026-04-24T06:32:29.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:45:40.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Added glossary term 'Inflammatory breast carcinoma' and a new Resources entry for Genetic and Rare Diseases Information Center. Updated the revision note from v3.4.3 to v3.5.0.
    Difference
    0.2%
    Check dated 2026-03-19T04:50:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for HR+ Inflammatory Breast Cancer Clinical Trial page.